1009-75-2

Usage

Uses

Used in Pharmaceutical Industry:
3'-Bromo-4'-fluoroacetanilide serves as a crucial building block for the synthesis of an array of drugs and pharmaceutical compounds. Its unique structure, with halogens and the aniline group, is exploited to create specific chemical reactions and interactions that are essential in drug development.
3'-Bromo-4'-fluoroacetanilide is used as a synthetic intermediate for [application reason] because of its ability to participate in various chemical reactions that facilitate the creation of new pharmaceutical entities. The presence of bromine and fluorine enhances the compound's reactivity, making it a valuable asset in the synthesis of drugs with desired therapeutic properties.
Furthermore, 3'-Bromo-4'-fluoroacetanilide is utilized as a precursor in organic chemistry research for [application reason] its potential to lead to the development of complex organic molecules. The structural features of the compound allow researchers to explore new pathways in organic synthesis, contributing to the discovery of novel chemical entities with potential applications in various fields.

Upstream product

• 656-64-4 3-bromo-4-fluoroaniline 
• 75-36-5 acetyl chloride 
• 64-19-7 acetic acid 
• 701-45-1 2-bromo-1-fluoro-4-nitrobenzene 
• 7439-89-6 iron 

Downstream Products

• 1350558-27-8 C₁₄H₁₉BFNO₃ 

Relevant academic research and scientific papers

COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF

Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof.

ORGANIC LIGHT-EMITTING DEVICE AND COMPOUND

An organic light-emitting device including a first electrode, a second electrode facing the first electrode, and an organic layer disposed between the first electrode and the second electrode, wherein the organic layer includes an emission layer, and wherein the emission layer includes a fluorescent compound represented by a specific formula described in the specification.

1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof

To provide a composition having a steroid C17,20-lyase inhibitory activity and useful as an agent for the prophylaxis or treatment of prostatism and tumors such as breast cancer. A compound represented by the formula: wherein R is a hydrogen atom or a protecting group, R1is a lower alkyl group or a cyclic hydrocarbon group, R2is an aromatic hydrocarbon group optionally having substituents or an aromatic heterocyclic group optionally having substituents, R3is a hydrocarbon group optionally having substituents, a hydroxyl group optionally having substituents, a thiol group optionally having substituents, an amino group optionally having substituents, an acyl group or a halogen atom, and n is an integer of 0 to 4, and a salt thereof have a steroid C17,20-lyase inhibitory activity, and are useful as an agent for the pophylaxis or treatment of prostatism and tumors such as beast cancer and the like.